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Nod2 Deficiency in mice is 
Associated with Microbiota 
Variation Favouring the Expansion 
of mucosal CD4+ LAP+ Regulatory 
Cells
A. Butera1, M. Di Paola2,3, L. Pavarini4, F. Strati  5, M. Pindo4, M. Sanchez6, D. Cavalieri  3, 
M. Boirivant1 & C. De Filippo  7
Nucleotide-binding Oligomerization Domain-2 (NOD2) mutations are associated with an increased risk 
to develop Crohn’s Disease. In previous studies, we have shown that Nod2−/− mice manifest increased 
proportion of Lamina Propria (LP) CD4+ LAP+ Foxp3− regulatory cells, when compared with Nod2+/+ 
mice, while CD4+ Foxp3 + regulatory cells were not affected. Here, we investigated the Nod2 gut 
microbiota, by 16S rRNA pyrosequencing, at steady state and after TNBS-colitis induction in mice reared 
separately or in cohousing, correlating the microbial profiles with LP regulatory T cells proportion and 
tissue cytokines content. We found that enrichment of Rikenella and Alistipes (Rikenellaceae) in Nod2−/− 
mice at 8 weeks of age reared separately was associated with increased proportion of CD4+ LAP+ Foxp3− 
cells and less severe TNBS-colitis. In co-housed mice the acquisition of Rickenellaceae by Nod2+/+ mice 
was associated with increased CD4+ LAP+ Foxp3− proportion and less severe colitis. Severe colitis was 
associated with enrichment of gram-negative pathobionts (Escherichia and Enterococcus), while less 
severe colitis with protective bacteria (Barnesiella, Odoribacter and Clostridium IV). Environmental factors 
acting on genetic background with different outcomes according to their impact on microbiota, predispose 
in different ways to inflammation. These results open a new scenario for therapeutic attempt to re-
establish eubiosis in Inflammatory Bowel Disease patients with NOD2 polymorphisms.
Nucleotide-binding Oligomerization Domain 2 (NOD2) is an innate immune cytoplasmic microbial receptor, 
belonging to the nucleotide-binding oligomerization domain, leucine-rich repeat family (NLR). Several genetic 
studies have highly correlated mutations in NOD2 domain with the development of Crohn’s disease (CD)1–4, 
though the mechanisms involved are still unclear, and perhaps linked to the NOD2 involvement in multiple pro-
cesses, such as the preservation of intestinal barrier integrity and immune homeostasis, autophagy and balance 
of the gut microbiota composition5–7.
It has been reported that while normal NOD2 supports responses to gut commensals, and thus control organ-
isms penetrating the intestinal lamina propria (LP), abnormal NOD2, with decreased function resulting from 
a polymorphism, exhibits a heightened inflammatory response due to blunted bacterial clearance8,9. However, 
Nod2−/− mice, despite showing increased LP CD4+ T cell-IFN-γ production, increased intestinal permeabil-
ity and bacterial translocation10,11, do not show signs of overt intestinal inflammation. In previous studies, we 
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have shown that Nod2−/− mice manifest increased colonic permeability, but this feature was associated with 
increased proportion of LP CD4+ LAP+ Foxp3− regulatory cells and increased TGF-β tissue content, when 
compared with Nod2+/+ mice, while CD4+ Foxp3+ regulatory cells were not affected. These features were asso-
ciated with a less severe colitis induced by 2,4,6-Trinitrobenzenesulfonic acid (TNBS) in Nod2−/− mice when 
compared to Nod2+/+ mice12–14.
It has been hypothesized that NOD2 mutations or deficiency can concur to shape the gut microbiota profiles, 
and thus the inflammatory disease development. Previous studies in humans showed gut microbiota alterations 
in mucosa of CD patients with NOD2 homozygous mutations15. In mice model, several studies reported the key 
role of Nod2 in the regulation of gut microbiota homeostasis7,15–20. Microbiota modifications related to Nod2 
deficiency were also found strictly dependent on animal housing conditions21,22.
In the present study, we investigated the microbial and mucosal immune profiles of Nod2−/− and Nod2+/+ 
mice reared independently or cohoused, at the steady state and after TNBS-colitis induction, to understand the 
impact of genetic background and environment on microbiota profiles and immune response.
Results and Discussion
In order to evaluate the effect of Nod2 genotype on microbiota-immune-system interactions, we performed 
meta-taxonomic analysis of gut microbiota in Nod2−/− and Nod2+/+ mice at different time points and housing 
conditions (Fig. 1 for experimental design and Methods).
Nod2−/− and Nod2+/+ mice show a clear separation of microbiota composition at 4 weeks 
of age. We found differences immediately before weaning (4 weeks of age) in the gut microbiota composition 
between Nod2−/− and Nod2+/+ mice (Fig. 2). At this time, alpha diversity analysis (Fig. 2A, B; observed OTUs 
and Shannon entropy estimation), showed a higher microbial richness in Nod2−/− compared to Nod2+/+ mice 
(Observed OTUs p = 0.03 t test, FDR correction).
Beta diversity analysis, calculated by using Non-metric Multi-Dimensional Scaling (NMDS) and Principal 
Coordinates Analysis (PCoA) on Bray-Curtis distances, discovered a clear separation between the two mice 
groups according to the different genotypes, indicating a great variability of microbial profiles between Nod2−/− 
and Nod2+/+ mice (Fig. 2C).
By meta-taxonomic analysis, we found different abundances in Bacteroidetes and Firmicutes between 
Nod2−/− and Nod2+/+ mice (by Linear discriminant analysis Effect Size-LEfSe; Fig. 2D). In particular, we 
observed that, although the proportion between Bacteroidetes and Firmicutes was well-balanced in Nod2−/− 
mice, Firmicutes was enriched when compared to Nod2+/+ mice, while Bacteroidetes was enriched in Nod2+/+ 
compared to Nod2−/− mice (Bacteroidetes and Firmicutes: in Nod2−/− 48.9% and 46.6% and in Nod2+/+ 
Figure 1. Experimental design on Nod2−/− and Nod2+/+ mice to investigate the effect of genetic background 
and housing conditions on microbiota-immune-system interactions. Black arrows indicate faecal sample 
collection for microbiota analysis at different time points: (i) at 4 weeks of age, (ii) at 8 weeks of age, and (iii) 
at day 3 after TNBS-colitis induction in cohoused and reared separately mice groups, respectively. At the three 
time points, mice were sacrificed to collect colon and test the proportion of LP CD4+ LAP+ Foxp3− T cells 
and tissue cytokines content.
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72.6% and 25.4%, respectively; Supplementary Tables S1–S2). Proteobacteria and Deferribacteres phyla were also 
enriched in Nod2−/− mice, but their abundances did not exceed the 1% (Fig. 2D).
These results are in agreement with previous observations showing in weaning Nod2−/− mice roughly twice 
the number of OTUs compared to Nod2+/+ mice and a clustering of microbiota composition between Nod2+/+ 
and Nod2−/− mice, with a significant abundance in Firmicutes in ileum content of adult and young Nod2−/− 
mice15. In addition, the increased abundance of Firmicutes observed in the present study in Nod2−/− mice is in 
agreement with initial observations reported in biopsies sampled from non-inflamed mucosal area of the termi-
nal ileum of CD patients that were homozygous for the Leu1007fs (SNP13) compared to CD patients that were 
homozygous for the WT NOD2 allele15. Similar results were also obtained in a subsequent study involving CD 
macroscopically disease-unaffected regions of the ileum23.
Regarding the Firmicutes phylum, LEfSe analysis showed a statistically significant enrichment of 
Lachnospiraceae in Nod2−/− (19.7%) compared to Nod2+/+ mice (5.4%), and Ruminococcaceae (6.4% in 
Nod2−/− vs 2.0% in Nod2+/+ mice; Fig. 2E). Other minor representative families, such as Corynebacteriaceae 
(Actinobacteria), Bdellovibrionaceae (Proteobacteria) and Deferribacteriaceae (Deferribacteres) were found 
enriched in Nod2−/− with respect to Nod2+/+ mice (Fig. 2D–E; Supplementary Table S2).
At lowest taxonomic level (Fig. 2E), in Nod2−/− mice we found enrichment of several genera, such as Alistipes 
(Bacteroidetes; 8.8% vs 2.5% in Nod2−/− compared to Nod2+/+ mice), Mucispirillum (Deferribacteres; 2.3% vs 
Figure 2. Microbiota comparison in mice by different genetic background. (A–C) Alpha and beta diversity 
measures at 4 weeks of age. (A,B) Alpha diversity. Box plots of (A) number of observed OTUs and (B) Shannon 
entropy in Nod2−/− and Nod2+/+ mice. Statistically significant differences were calculated by pairwise 
comparisons using Student t test with FDR correction; *p-value < 0.05. (C) Beta diversity. NMDS and Principal 
coordinate analysis (PCoA) based on the Bray-Curtis distance metric (PERMANOVA, p-value = 0.015). 
(D,E) LEfSe analysis shows a statistically significant enrichment based on different genotypes at 4 weeks of 
age. (D) Differences in bacterial phyla between Nod2−/− and Nod2+/+ mice. (E) Cladogram showing the 
most discriminative bacterial clades by comparison of Nod2−/− and Nod2+/+ microbiota. Coloured regions/
branches indicate differences in the bacterial population structure between Nod2−/− and Nod2+/+ mice at 
4 weeks. Regions in red indicate clades that were enriched in Nod2−/− mice, while regions in green indicate 
clades that were enriched in Nod2+/+ mice. LEfSe results indicate a sequentially significant ranking between 
the two groups (Alpha value = 0.05 for the factorial Kruskal-Wallis test among classes; the threshold for the 
logarithmic LDA score was 2.0).
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0.3% in Nod2−/− compared to Nod2+/+ mice) and other minor representative genera belonging to Firmicutes 
(Anaerotruncus, Butyrricicoccus, Clostridium cluster XIVa and XIVb, Flavonifractor, Jeotgalicoccus, Lachnospiracea 
incerte sedis, and Oscillibacter) together with Corynebacterium (Actinobacteria) (Supplementary Table S2).
In Nod2+/+ mice, we observed a statistically significant enrichment in Porphyromonadaceae (Bacteroidetes; 
50.62% vs 34.6% in Nod2+/+ compared to Nod2−/− mice), Enterobacteriaceae, Sutterellaceae (Proteobacteria), 
and Coriobacteriaceae (Actinobacteria) families (Fig. 2E; Supplementary Table S2). Barnesiella, a member 
of the Porphyromonadaceae family, known to regulate the microbial composition24 and inhibit clostridia and 
other potentially harmful microbes25, was the most abundant genus (28.3% vs 16.7% in Nod2+/+ compared 
to Nod2−/− mice). We found also enrichment of Odoribacter (Porphyromonadaceae; 2.1% vs 1% in Nod2+/+ 
compared to Nod2−/− mice), Bacteroides (Bacteroidetes; 4% vs 0.7% in Nod2+/+ compared to Nod2−/− mice), 
and other minor representative genera, including the pathobionts Escherichia/Shigella (Enterobacteriaceae), 
Enterorhabdus (Coriobacteriaceae)26 and Parasutterella (Sutterellaceae)27 (Fig. 2E; Supplementary Table S2).
These results are partially in agreement with previous reported data28 that showed an over-representation 
of Alistipes, in Nod2−/− mice microbiota and a depletion in bacteria belonging to Proteobacteria, such as 
Escherichia/Shigella genus20, that in our study was enriched in Nod2+/+ mice.
To predict how taxonomic differences between microbiota of Nod2−/− and Nod2+/+ mice could affect 
their microbial metabolic potential, we applied PICRUSt (Phylogenetic Investigation of Communities by 
Reconstruction of Unobserved States)29 (see Methods). LEfSe analysis, performed on PICRUSt output 
(Supplementary Fig. S1), showed differentially enriched functional classes (KEGG categories) between Nod2−/− 
and Nod2+/+ mice. Interestingly, although in both microbiomes we identified a common core of metabolic 
capabilities related to carbohydrate, lipid and amino acid metabolism, in Nod2+/+ mice we observed signif-
icant enrichment of functions related to lipopolysaccharides (LPS) biosynthesis. It is well known that LPS is a 
component of cell wall of Gram-negative bacteria. This result correlates with the observed higher abundance 
of Gram-negative taxa, such as Bacteroidetes phylum, Porphyromonadaceae family, Escherichia/Shigella and 
Parasutterella genera in Nod2+/+ mice (Fig. 2D–E) compared to the abundance of Firmicutes (Gram-positive) 
observed in Nod2−/− mice.
In Nod2−/− mice, we found an enrichment of functions related to cell motility (flagellar assembly, bacterial 
chemotaxis and bacterial motility proteins), membrane transport (secretion system, sulfur relay system, ansamy-
cin biosynthesis), and cellular processes and signaling. These functions could be associated to the potential ability 
of some microorganisms to adapt and respond to external stimuli.
Colonic tissue Immunologic profile. In order to correlate microbiota composition with mucosal 
immune-profile, we analyzed Nod2+/+ and Nod2−/− colonic tissue samples from 5 mice/group for cytokine 
mRNA tissue content and proportion of LP CD4+ LAP+ Foxp3− regulatory cells. We found a significant 
increase in the percentage of LP CD4+ LAP+ Foxp3− regulatory cells in Nod2−/− mice when compared with 
Nod2+/+ mice (6.28 ± 1.8 vs 2.5 ± 1.4, mean ± SE, p < 0.05, respectively). As regard colonic tissue cytokine 
mRNA content, in Nod2−/− mice we observed a significant increase of TGF-β mRNA content compared to 
Nod2+/+ mice (8.3 ± 2 vs 2 ± 0.4 AU, mean ± SE, p < 0.05, respectively) and an increase (although not signifi-
cant) in IL-10 mRNA content (7.2 ± 2.2 vs 3.6 ± 0.1 AU, mean ± SE, p = 0.31, respectively).
Notably, as described above, the microbiota of Nod2−/− mice at 4 weeks of age was enriched of 
Lachnospiraceae and Ruminococcaceae, two bacterial families encompassing known butyrate-producers30, and 
other protective bacteria, such as Clostridium cluster XIVa, involved in CD4+ Foxp3+ regulatory T cells accu-
mulation31,32, Alistipes and Butyriciccous, two genera reported to be depleted in human IBD samples28,33 and able 
to protect from colitis in mice33,34 (Fig. 2E). On the other hand, Nod2+/+ microbiota was relatively enriched of 
Gram-negative and LPS-producer pathobionts, such as Escherichia/Shigella, and Parasutterella (Fig. 2E), found in 
association with inflammation, colitis and enriched in the gut microbiota of CD patients27,35,36.
Taken together our data show, at this time point, an association between the enrichment of protective bacteria 
in Nod2−/− microbiota and the increase of LP CD4+ LAP+ Foxp3− regulatory cells and anti-inflammatory 
cytokines.
Change of cage, grouping with other mice from different mothers minimize the difference in 
microbiota observed before weaning in mice reared separately. At weaning (4 weeks of age), some 
male mice from different mothers/cages were grouped in new cages and kept separated according to the genetic 
background (Nod2−/− or Nod2+/+).
Analysis of faecal microbiota composition of mice reared separately at 8 weeks of age revealed a decrease 
in alpha diversity in Nod2−/− mice compared with microbiota of the same mice at 4 weeks (Observed OTUs 
p = 0.033 t test FDR correction; Fig. 3A,B).
Few differences in microbial profiles were observed considering the different genetic backgrounds, as indi-
cated also by beta diversity measures (Fig. 3 and Supplementary Fig. S2).
With respect to the 4 weeks of age, at this time point (8 weeks) we observed that the proportion of 
Bacteroidetes and Firmicutes in the two groups of mice was unchanged (Supplementary Table S1). In particu-
lar, we found an increase of Bacteroidetes and a reduction of Firmicutes in Nod2−/− when compared with 
Nod2+/+ mice (Bacteroidetes 71% vs 57%; Firmicutes 27% vs 40%, respectively). The most abundant taxa, such 
as Porphyromonadaceae (54.8% vs 49.7% in Nod2−/− and Nod2+/+ mice respectively) and Lachnospiraceae 
families (11.9% vs 12.8% in Nod2−/− and Nod2+/+ mice respectively), and Barnesiella genus (23.8% vs 20.9% in 
Nod2−/− and Nod2+/+ mice respectively) were comparable in terms of relative abundance either in Nod2−/− 
or Nod2+/+ mice when reared separately (Supplementary Table S2). These data are partly in agreement with pre-
viously reported data that showed in colon of 10 weeks old Nod2−/−mice a higher proportion of Bacteroidetes 
and a lower proportion of Firmicutes18. However, although we observed small differences in the same direction, 
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we did not observe a significant increase in bacteria assigned to the Porphyromonadaceae family and a concomi-
tant significant decrease in bacteria from Lachnospiraceae in Nod2−/− mice, as reported in the above mentioned 
study. These differences might be due to the different samples evaluated (colons in the reported study, and fae-
ces in the present study). However, by LEfSe analysis, some differential abundances in bacterial taxa between 
Nod2−/− and Nod2+/+ mice reared separately were still present at 8 weeks of age (Fig. 3B). In particular, in 
Nod2−/− mice, the enrichment of Alistipes (5.4%; Rikenellaceae) is still observable. In addition, at this time-point 
enrichment in Eubacteriaceae and Eryspelotrichaceae families, and genera <1% in relative abundance, such as 
Rikenella (Rikenellaceae), Eubacterium (Eubacteriaceae) and Allobaculum (Eryspelotrichaceae) are observed in 
Nod2−/− mice microbiota, confirming in part previously reported data19. In Nod2+/+ mice, Lactobacillus (24% 
vs 10% in Nod2+/+ and Nod2−/− mice respectively) was the predominant genus. Coriobacteriaceae family and 
genera minor than 1% in terms of relative abundance, such as Butyrricicoccus, Clostridium XIVa, Enterohabdus 
and Ruminococcus significantly differentiates the microbiota composition (Fig. 3B; Supplementary Table S2). 
These data suggest that in Nod2−/− and Nod2+/+ at 4 weeks of age (weaning) other factors such as maternal 
effect and/or cage effect, may magnify differences in the microbiota, which are minimized when a more hetero-
genic microbiota resulting from cohousing with mice of different mothers and from different cages is acquired. It 
is interesting to note that some genera as Clostridium XIVa and Butyrricicoccus that were enriched in Nod2−/− 
mice microbiota at 4 weeks of age are now enriched in the Nod2+/+ mice microbiota. At the same time, some 
family/genus enrichment (i.e. Rikenellaceae/Alistipes) persists in Nod2−/− mice also at this time-point. The per-
sistence of a specific component of the microbiota might indeed be the expression of the influence of genetic 
Figure 3. Microbiota comparison between Nod2−/− and Nod2+/+ mice at 8 weeks of age in different housing 
conditions. (A,C) Alpha diversity measures in mice (A) reared separately and (C) in cohousing. Box plots of 
number of observed OTUs and Shannon entropy in Nod2−/− and Nod2+/+ mice (A) reared separately at 4 
and 8 weeks of age and (C) in cohousing at 8 weeks of age. Statistically significant differences were performed 
by pairwise comparisons using Student t test with FDR correction. For each significant pairwise comparison 
p-value < 0.05 are indicated by different letters (“a”, “b”, “c”, and “d”). (B–D) Microbiota profile comparison 
in Nod2−/− and Nod2+/+ mice at 8 weeks (B) reared separately and (D) in cohousing. Cladogram showed 
the most discriminative bacterial clades identified by LEfSe analysis. Coloured regions/branches indicate 
differences in the bacterial population structure between Nod2−/− and Nod2+/+ mice at 8 weeks. Regions 
in red indicate clades that were enriched in Nod2−/− mice, while regions in green indicate clades that were 
enriched in Nod2+/+ mice. LEfSe results indicate a sequentially significant ranking between the two groups 
(Alpha value = 0.05 for the factorial Kruskal-Wallis test among classes; the threshold for the logarithmic LDA 
score was 2.0).
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differences (i.e. the absence of functional Nod2 gene) between the two lineages. This view is reinforced by the 
recent demonstration that NOD2 deficiency has indeed a dominant effect on microbial dysbiosis18,19.
Colonic tissue Immunologic profile in 8 weeks-old mice reared separately. To evaluate at this time 
point the proportion of LP CD4+ LAP+ Foxp3− regulatory cells and cytokine mRNA tissue content between 
Nod2−/− and Nod2+/+ mice reared separately, some mice (5 mice/group) were sacrificed at 8 weeks of age. As 
shown in Table 1, we observed differences in IL-10 and in TGF-β tissue content that were significantly higher in 8 
weeks-old Nod2−/− mice than in Nod2+/+ mice when reared separately. As previously shown12, proportion of 
colonic CD4+ LAP+ Foxp3− regulatory cells were also significantly higher in Nod2−/− than in Nod2+/+ tis-
sue samples. This result could be associated with high microbial richness, as observed by alpha diversity measure 
(Fig. 3A), and with the presence of protective bacteria, such as Alistipes, Eubacterium, Allobaculum, known for 
beneficial effects on the colon mucus barrier37, as observed by LEfSe analysis (Fig. 3B).
Effect of co-housing on microbiota composition. In order to evaluate the microbiota components 
influencing the regulatory T cells and cytokines profile in mucosal tissue, we analysed microbiota compo-
sition in Nod2−/− and Nod2+/+ mice after 4 weeks of cohousing. When mice of the two different lineages 
were cohoused, an increase of alpha diversity in microbiota of Nod2+/+ mice was observed with respect to 
either the same mice at 4 weeks of age or mice of the same genetic background reared separately (Fig. 3A–C; 
p value < 0.05 Nod2+/+ cohousing vs reared separately). The differences in alpha diversity between cohoused 
Nod2−/− and Nod2+/+ were reduced when compared with mice reared separately (Fig. 3A–C), indicating sim-
ilar species richness in gut microbial community and suggesting a possible sharing of microbial taxa. Indeed, few 
differences were observed between the two genetic backgrounds, as indicated by beta diversity (Supplementary 
Fig. S2). In particular, both Nod2−/− and Nod2+/+ mice showed similar abundances of Lactobacillus (14.83% vs 
14.86% in Nod2−/− and Nod2+/+ mice respectively), Barnesiella (16.4% vs 15.75% in Nod2−/− and Nod2+/+ 
mice respectively), Bacteroides (1.74% vs 1.50% in Nod2−/− and Nod2+/+ mice respectively), as previously 
reported by Robertson et al.21, and Allobaculum (1.82% vs 1.06% in Nod2−/− and Nod2+/+ mice respec-
tively) (Supplementary Table S2). However, LEfSe analysis showed very few differences, in particular related to 
Porphyromonadaceae family in Nod2−/− mice, that was previously (4 weeks of age) enriched in Nod2+/+ mice 
(Fig. 3D; Supplementary Table S2). Notably, in Nod2+/+ mice, an unknown genus belonging to Lachnospiraceae 
family was significantly enriched, together with the minor representative genera, such as Alistipes (6.44% vs 
4.29% in Nod2+/+ and Nod2−/− mice respectively), Rikenella (0.85% vs 0.42% in Nod2+/+ and Nod2−/− mice 
respectively) that was previously (4 weeks of age) enriched in Nod2−/− mice (Fig. 3D; Supplementary Table S2).
In accordance with the above described data prediction of functional contribution of microbial communities 
by LEfSe analysis performed on PICRUSt results (Supplementary Fig. S3) showed that among the metabolic 
functions, an enrichment in functions related to membrane and intracellular structural molecules, in particular 
LPS biosynthesis, are now present in Nod2−/− cohoused mice, as opposite as the observed enrichment at 4 weeks 
of age in Nod2+/+ mice. This seems almost certainly due to the observed inverted proportion of Bacteroidetes 
between 4 and 8 weeks of age (Supplementary Table S1), and other Gram-negative bacteria (Vampirovibrio). The 
LPS biosynthesis is relevant in determining the homeostatic response to microbiota, therefore imbalance in its 
synthesis may influence the severity of colitis38.
In Nod2+/+ cohoused mice, enriched functions related to cell motility (Flagellar assembly, Bacterial chemot-
axis and Bacterial motility proteins), membrane transport (sulfur relay system, ABC transporters) and ansamycin 
biosynthesis were found, as previously observed in Nod2−/− mice at 4 weeks of age.
Taken together the data leads to the conclusion that cohousing favours the sharing of microbiota components. 
These data are partially in contrast with previous data, which demonstrated no difference in microbiota compo-
sition in co-housed mice21,22. The duration of cohousing, short in our studies, mice housed together for the entire 
studies in the above cited studies21,22, and or the different method utilized in the present study for microbiota 
composition assessment and analysis may explain the different results.
Colonic tissue Immunologic profile of cohoused mice. As for Nod2−/− and Nod2+/+ reared sep-
arately, 5 mice/group were sacrificed after 4 weeks of cohousing (8 weeks of age) for the assessment of colonic 
cytokine content and proportion of LP T regulatory cells. As shown in Table 1, in cohoused mice percentage of 
LP CD4+ LAP+ Foxp3− cells is higher in Nod2+/+ mice than in Nod2−/− mice. This latter showed values 
comparable to that observed in Nod2+/+ mice reared separately. This result could be associated with enrichment 
of Alistipes and Rikenella (both belonging to Rikenellaceae family) as observed by LEfSe analysis (Fig. 3B–D). In 
fact, the increased proportion of CD4+ LAP+ Foxp3− cells seems associated with enrichment in Rickenellaceae 
Mice
LAP+ Foxp3− cells (percentage of LP 
CD3+ CD4+ gated cells) mean ± SE
IL-10 (mRNA content in colonic 
tissue; Arbitrary Units) mean ± SE
TGF-β (mRNA content in colonic 
tissue; Arbitrary Units) mean ± SE
Nod2−/− 4.6 ± 1.0* 7 ± 1.2* 4.9 ± 0.9*
Nod2+/+ 2.7 ± 0.3 4.1 ± 0.5 2.5 ± 0.2
Nod2−/− cohoused 2.6 ± 0.8** 4.3 ± 0.7 1.4 ± 0.1
Nod2+/+ cohoused 6 ± 1.1 6.7 ± 1.5 2.2 ± 0.6
Table 1. Immune profile of mice at 8 weeks of age. Statistical significance by Mann–Whitney U-test: *p < 0.05 
Nod2−/− vs Nod2+/+; **p < 0.05 Nod2−/− cohoused vs Nod2+/+ cohoused.
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found in no-cohoused Nod2−/− mice microbiota and in co-housed Nod2+/+ mice microbiota. An increased 
abundance of Alistipes was recently found to be associated with administration of curcumin in mice39, a spice 
known for its beneficial effect on experimental colitis40 and possibly in patients with IBD41. Furthermore, it has 
been shown in vitro and in pre-clinical models, that curcumin is able to modulate bowel inflammation, through 
its ability to enhance IL-10-mediated effects42. Since we have previously shown that CD4+ LAP+ Foxp3− cells 
expansion is IL-10 dependent43 it is tempting to speculate that the variation in the proportion of CD4+ LAP+ 
Foxp3− cells observed in the different housing conditions might be related to the different enrichment in 
Rickenellaceae, particularly Alistipes. This hypothesis is reinforced by the observation made in the present study 
concerning the significant increase in IL-10 tissue content in non-cohoused Nod2−/− vs Nod2+/+ mice and 
the increased IL-10 tissue content in co-housed Nod2+/+ vs Nod2−/− mice. Further observations suggest a 
link between Alistipes and CD4+ LAP+ Foxp3− cells. It has been reported, in a study utilizing faecal microbiota 
transplantation from colonic cancer patients and healthy individuals into germ-free mice that, among others, 
Alistipes positively correlated with increased tumour burden in recipient mice13. It has also been reported, in 
the context of the suggestion that T regulatory cells promote tumour development and metastasis by inhibiting 
the proliferation of effector T lymphocytes, an increased percentage of LAP+ CD4+ T cells in peripheral blood 
and in tumour tissue of patients with colorectal cancer that correlates with tumour progression via the CD4+ 
LAP+ Foxp3− production of IL-10 and TGF-β44. Further studies, directly investigating the effect of Alistipes on 
the generation of CD4+ LAP+ Foxp3− regulatory cells are needed to confirm this hypothesis. Since a recent 
study25, aimed at understanding the interaction and changes of bacterial communities (e.g. microbial-interaction 
network and dynamic model between Barnesiella and Clostridium difficile), confirms once more, that microbial 
networks, rather than single strains or species, are associated to complex immune phenotypes, it is also likely that 
the unclassified microbial genus belonging to Lachnospiraceae that showed the same trend of Alistipes, and others 
beneficial bacteria (i.e. Rickenella, Eubacterium and Odoribacter), could create a multi-genera network associated 
to the generation of CD4+ LAP+ Foxp3− cells.
As additional confirmatory finding, colonic TGF-β mRNA tissue content was higher in Nod2−/− than in 
Nod2+/+ mice reared separately (Table 1), as observed in our previous study12, but was higher in Nod2+/+ mice 
than in Nod2−/− mice when the two groups of mice were co-housed (Table 1). Taken together, our data suggest 
that Nod2 deficiency and related differences in microbiota composition impact on immune-response, especially 
on the proportion of LAP+ CD4+ T regulatory cells. This observation is not in agreement with recent studies 
using Nod2 deficient mice transplanted with wild-type bone marrow cells and vice versa17. These studies showed 
that epithelial barrier functions and GALT composition are related to the lack of Nod2 in the hematopoietic cells 
and that the dysbiosis observed in Nod2−/− mice in these studies, does not play a crucial role in the control 
of immune-response at the homeostasis. In the present study, indeed we show that the observed changes in 
mucosal immune-profile are clearly related to the acquired microbial profiles as demonstrated by the observa-
tions reported in co-housed mice. These discrepancies could be partially reconciled by the observation that in the 
above mentioned studies regulatory cells and cytokines were not analysed.
TNBS-colitis shows different and opposite severity in Nod2−/− and Nod2+/+ mice reared 
separately or cohoused. In order to confirm previously reported data on different severity of TNBS coli-
tis in Nod2−/− and Nod2+/+ mice and evaluate the relationship with microbiota profiles, in each of the four 
groups of mice at the age of 8 weeks, colitis was induced by intra-rectal administration of TNBS. As previously 
reported12, when reared separately, Nod2−/− mice showed a significant less severe colitis compared to Nod2+/+ 
mice; as opposite, in cohoused groups, Nod2−/− mice showed a more severe colitis when compared to Nod2+/+ 
mice (Fig. 4). Additionally, Nod2+/+ mice co-housed showed a less severe colitis when compared to TNBS coli-
tis induced in Nod2+/+ mice reared separately. Indeed the course of colitis was comparable in both Nod2+/+ 
cohoused and Nod2−/− mice reared separately, as indicated by the weight loss (Fig. 4A). The different severity 
of colitis was also reflected by the colonic mRNA content of proinflammatory cytokines (Fig. 4B). We have pre-
viously demonstrated by adoptive transfer studies12 that the observed protection from TNBS-colitis in Nod2−/− 
mice reared separately was dependent on the increased proportion of LP CD4+ LAP+ Foxp3− cells observed in 
these mice. In the present study, severity of colitis was strictly related to the different proportion of CD4+ LAP+ 
Foxp3− observed before TNBS treatment (at 8 weeks of age; Table 1) in Nod2−/− and Nod2+/+ mice under dif-
ferent housing conditions, confirming the direct influence of CD4+ LAP+ Foxp3− regulatory cells on severity of 
colitis. Although the observation of less severe TNBS colitis in Nod2−/− mice reared separately from Nod2+/+ 
is in contrast with previous studies in which an increased severity of colitis in Nod2−/− mice compared with 
Nod2+/+ mice was reported10, it is possible that the observed differences reside in differences related to the var-
ious facilities favouring or not a pro-inflammatory microbiota in Nod2−/− mice.
As expected, severe colitis (as observed in Nod2+/+ mice reared separately, and in Nod2−/− mice co-housed) 
was associated with a reduction of alpha-diversity compared with the genotype and housing condition counter-
parts (Figs 5A, B and 6). This is in agreement with the notion reported in several human IBD studies that micro-
bial richness is reduced in microbiota of patients affected by inflammatory diseases, especially IBD45. In addition, 
beta diversity (Fig. 5C) showed a clustering of cohoused Nod2−/− mice samples (more severe colitis) from sam-
ples of Nod2+/+ cohoused mice and Nod2−/− mice reared separately (both developing less severe colitis).
Due to the mice coprophagy, co-housing between two different genetic lineages represents a mean to evaluate 
the effects of acquisition of transferable microbiota compounds from one lineage to the other. The first strik-
ing effect of this procedure consists in the very different severity of TNBS colitis and accompanying profile of 
inflammatory cytokines in the two lineages. In fact, TNBS colitis that was more severe in Nod2+/+ mice reared 
separately, is now less severe than the one observed in Nod2−/−, while the opposite is true for Nod2−/− mice.
Comparing the abundance of phyla between these four groups of mice, some significant differences emerged 
(Fig. 6 and Supplementary Table S1). First, comparison between the pair of less severe colitis (observed in 
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Nod2−/− reared separately and in Nod2+/+ mice cohoused), showed a certain balance in the Bacteroidetes/
Firmicutes ratio, suggesting that in Nod2+/+ cohoused mice the acquisition of Nod2−/− microbiota expands 
the Firmicutes phyla (Supplementary Table S1), under the pressure of the inflammatory agent TNBS. It is 
Figure 4. Nod2−/− mice exhibit less severe TNBS-colitis compared with Nod2+/+ mice reared separately, but 
more severe colitis than Nod2+/+ mice when co-housed. Mice were administered intra-rectal TNBS to induce 
TNBS-colitis (see methods). (A) Body weight changes of mice. Each point represents mean ± SE weight at day 
3 from induction of colitis (day 0) expressed as percentage of day 0 weight and derived from 5 mice/group; 
p = 0.01 and p = 0.02 (Student’s t test) Nod2−/− vs Nod2+/+ mice reared separately or co-housed, respectively. 
(B) Cytokine mRNA colonic tissue content. Mice were administered intra-rectal TNBS to induce TNBS-colitis. 
At day 3 from colitis induction mice were sacrificed and colons were removed to be processed as described in 
material and method section. Statistical differences were evaluated by Mann–Whitney U-test.
www.nature.com/scientificreports/
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interesting to note that Firmicutes were indeed more represented in Nod2−/− mice at 4 weeks of age (Fig. 2D 
and Supplementary Table S1). Similarly, acquisition of Nod2−/− microbiota by Nod2+/+ mice was associ-
ated, as in Nod2+/+ mice reared separately, with expansion of Proteobacteria and reduction of Firmicutes and 
Bacteroidetes (Fig. 6 and Supplementary Table S1), that, altogether, represented about the 95–98% of bacteria at 
4 weeks and 8 weeks of age in both housing conditions. As known30, unregulated intestinal inflammation results 
in an environment favouring bacterial expansion of Proteobacteria (44% in Nod2−/− cohoused and 20% in 
Nod2+/+ mice reared separately) and corresponding reduction in Firmicutes. This was corroborated by a domi-
nance of Escherichia/Shigella and Enterococcus genera observed in severe colitis (Nod2+/+ mice reared separately 
and co-housed Nod2−/− mice), and a reduction of Barnesiella (Fig. 5D, E; Supplementary Table S2), involved in 
protection from experimental colitis46.
Less severe colitis (Nod2+/+ cohoused mice and in Nod2−/− mice reared separately) was associated with 
no expansion of Proteobacteria (under 1–2%; Supplementary Table S1), and enrichment of Clostridium cluster 
IV, that include F. prausnitzii, a known bacteria with anti-inflammatory properties and Odoribacter, a known 
SCFA-producer that have trophic function on epithelial cells47, in the respective groups (Fig. 5D, E).
Regarding functional contribution of microbial communities that could be associated with severity of colitis, 
LEfSe analysis performed on PICRUSt prediction confirmed an enrichment in functions related to membrane 
and intracellular structural molecules, especially LPS biosynthesis, cell motility (Flagellar assembly, Bacterial 
chemotaxis and Bacterial motility proteins) in Nod2−/− cohoused mice (Supplementary Fig. S4), and an enrich-
ment in Arachidonic acid metabolism in microbiota of Nod2+/+ mice reared separately (Supplementary Fig. S5). 
Both LPS, from Gram-negative bacteria, and metabolites of arachidonic acids have immunostimulatory and 
endotoxic properties which mediate inflammatory reactions48.
Figure 5. Microbiota comparison in Nod2−/− and Nod2+/+ mice after TNBS-induced colitis. (A–C) 
Alpha and beta diversity measures. (A,B) Alpha diversity. Box plots of (A) number of observed OTUs and (B) 
Shannon entropy in Nod2−/− and Nod2+/+ mice cohoused or reared separately after 3 days of TNBS-induced 
colitis. Pairwise comparisons using t test with FDR correction. For each significant pairwise comparison 
p-value < 0.05 are indicated by different letters (“a”, “b”, “c”, and “d”, “e”) (C) Beta diversity. NMDS and PCoA 
obtained by Bray-Curtis distances (PERMANOVA, p = 0.001). (D-E) LEfSe analysis. Cladogram showed the 
most discriminative bacterial clades. Coloured regions/branches indicate differences in the bacterial population 
structure between Nod2−/− and Nod2+/+ mice after TNBS-induced colitis (D) in cohousing and (E) reared 
separately. LEfSe results indicate a sequentially significant ranking between the two groups (Alpha value = 0.05 
for the factorial Kruskal-Wallis test among classes; the threshold for the logarithmic LDA score was 2.0).
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The severe condition of colitis presents in Nod2−/− mice co-housed with the Nod2+/+ has characteristics 
similar to microbial dysbiosis presents in CD patients47. Both conditions has been characterized by a higher abun-
dance of Proteobacteria, a reduction of Bacteroidetes and a lower abundance of Firmicutes, particularly within 
the Clostridium XIVa and IV clusters23,49. Studies of correlation between relative abundance of bacterial taxa and 
number of minor alleles at known IBD risk loci, including fine mapping of multiple risk alleles in NOD2 gene 
exon, identified a significant association between NOD2 risk allele count and increased relative abundance of 
Enterobacteriaceae50. Thus, genetic influence indeed contributes to the inflammation-mediated dysbiosis.
The above observations suggest that genetic differences might induce differences in the “core” microbiota pro-
file. These differences influence the generation of regulatory T cells, particularly CD4+ LAP+ Foxp3− cells that 
are responsible for the response to inflammatory stimuli. As a consequence of different severity of inflammation, 
the microbiota of inflamed mice showed different prevalence of bacterial taxa. This hypothesis was corroborated 
by the correlation we observed with different tissue content of cytokines. In fact, Barnesiella and Bacteroidales_
unknown were inversely correlated with IL-6 and IL-17, and Ruminococcus with IFN-γ, while Escherichia/Shigella 
and Enterococcus were directly correlated with IL-6 and IL-17 (Fig. 7).
Conclusions
Taken together the data lead to the following major conclusions: (i) Nod2 deficiency is characterized by increased 
immune-regulation associated with a highly diverse microbial profiles that favours expansion of regulatory cells, 
particularly CD4+ LAP+ Foxp3− cells, preventing the onset of intestinal inflammation in response to mild 
(TNBS) external stimuli; (ii) environmental factors (cohousing) intervening between the age of weaning and 
young adulthood (4–8 weeks of age), a period characterized by microbiota instability, favours the sharing of 
microbial species. Nod2−/− endow potentially useful microbes beneficial for Nod2+/+ when colitis occurs, 
providing them with more “volatile” microbial families and genera, most likely linked to the relative short time of 
colonization. On the other hand, Nod2+/+ can expose Nod2−/− to microbial species that these cannot normally 
control, and that can be potentially harmful during colitis.
Thus, at least in certain circumstances, co-housing is able to alter the genetic-induced microbiota compo-
sition, through reduction of microbial richness and expansion of Proteobacteria to the detriment of the main 
Figure 6. Summary of alpha diversity measure, microbial and immunologic profiles in Nod2−/− and 
Nod2+/+ mice reared separately or cohoused at different time points. Alpha diversity, Bacteroidetes/
Firmicutes (B/F) ratio and CD4+ LAP+ Foxp3− levels were compared at 4 weeks, 8 weeks of age, and after 
TNBS-colitis. Interestingly, (A) in mice groups developing severe colitis (Nod2−/− cohoused and Nod2+/+ 
reared separately), progressive reduction of alpha diversity, unbalanced B/F ratio and reduction of CD4+ 
LAP+ Foxp3− proportion (at 8 weeks), and expansion of Proteobacteria (after TNBS-colitis) were observed, 
conversely to (B) Nod2−/− reared separately and Nod2+/+ cohoused developing less severe colitis.
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phyla Bacteroidetes and Firmicutes, potentially contributing to the onset of a severe inflammation in Nod2−/−. 
This notion might be of relevance in the therapeutic attempt to re-establish eubiosis in CD patients with NOD2 
polymorphisms.
Figure 7. Correlation analyses among bacterial taxa abundance and mucosal cytokines in Nod2−/− mice after 
TNBS-induced colitis. (A) Spearman’s r correlation analysis among bacterial relative abundances (taxa with 
relative abundance <0.1%) and mucosal cytokines expression measured by RT-qPCR (IL-10, INF-γ, TGF-β, 
IL-17 and IL-6 normalized using the HK gene CD3). Solid circles represent the degree of correlation among the 
variables taken into account. Crossed circles indicate non-significant correlations; statistically significant results 
are indicated with p < 0.05. (B) Correlation analysis among bacterial taxa and mucosal cytokines according to 
mild and severe colitis in Nod2−/− mice in different housing conditions.
www.nature.com/scientificreports/
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Methods
Animals, housing conditions and sampling of feces and tissues. Mice. Nod2+/+ and Nod2−/− 
mice on C57BL/6 background were kindly donated by Peter J Murray, Department of Infectious Diseases and 
the Department of Immunology, St Jude Children’s Research Hospital, Memphis, Tennessee, USA. At the Istituto 
Superiore di Sanità (Rome, Italy), Nod2−/− mice and control Nod2+/+ mice had been re-derived by embryo 
transfer into littermate foster mothers raised in the same SPF animal facility and in the same cage. Nod2−/− and 
Nod2+/+ mice were maintained in different cages and trio breeding groups (defined as one adult male and two 
adult females) have been used to obtain better performance in the breeding. Nod2−/− and Nod2+/+ mice were 
maintained in SPF conditions in the animal facility at the Istituto Superiore di Sanità. All mice were housed with 
free access to food and water. Pathogen-free conditions were monitored every 6 months in accordance with the 
full set of FELASA high standards recommendations. All animal studies were approved by the Animal Care and 
Use Committee of the Istituto Superiore di Sanità. All procedures were performed in accordance with the Guide 
for the Care and Use of Laboratory Animals and were approved by the Italian Ministry of Health (Reference: n. 
4 42 /2015-PR).
A total of 50 mice were included in the experimental design, as following: at time of weaning (4 weeks of age), 
Nod2+/+ (n = 25) and Nod2−/− (n = 25) males mice have been separated from their mothers and distributed in 
new cages so that each cage contained mice born to different mothers. A total of 5 mice/group were scarified for 
cytokine mRNA tissue content and proportion of LP CD4+ LAP+ Foxp3− regulatory cells. Groups of Nod2−/− 
(n = 10) and Nod2+/+ (n = 10) mice were reared separately, while other groups were co-housed in the same cage 
for 4 weeks (n = 10 Nod2−/− mice and n = 10 Nod2+/+ mice).
At 8 weeks of age, a total of 5 mice/group were scarified for cytokine mRNA tissue content and propor-
tion of LP CD4+ LAP+ Foxp3− regulatory cells. The remaining mice (n = 10 Nod2−/− and n = 10 Nod2+/+) 
reared separately or co-housed, colitis was induced by administration of 2,4,6-trinitrobenzenesulfonic acid 
(TNBS) (3.5 mg; Sigma-Aldrich, Saint Louis, USA) delivered in 150 µl of 50% ethanol per rectum as previously 
described12.
Faeces samples collection. Faeces were collected at different time points: (i) at 4 weeks of age (at weaning, before 
the housing conditions were established; n = 5 faecal samples from Nod2+/+ and n = 5 from Nod2−/− mice); 
(ii) at 8 weeks of age (before TNBS-colitis induction; n = 10 faecal samples from Nod2+/+ mice and n = 10 from 
Nod2−/− mice, randomized to cohousing and no-cohousing conditions), and (iii) at day 3 after TNBS colitis 
induction (n = 10 faecal samples from Nod2+/+ mice and n = 10 faecal samples from Nod2−/− mice equally 
distributed in different housing conditions). A total of 50 faecal samples were collected immediately after defaeca-
tion and stored at −80 °C until analysed for microbiota composition. Some mice belonging to the different groups 
were sacrificed at 4, 8 weeks of age and at day 3 after TNBS-colitis induction for evaluation of tissue cytokines and 
at 4 and 8 weeks of age for evaluation of LP regulatory T cells.
Tissue collection. Groups of 5 mice from different housing conditions were sacrificed at 4 and 8 weeks of age. 
The remaining mice (n = 10 Nod2+/+ mice and n = 10 from Nod2−/− mice in different housing conditions) 
were sacrificed at day 3 after TNBS-colitis induction. Colons were collected for the evaluation of the frequency 
of regulatory cells from Lamina Propria Mononuclear Cells (LPMC) as previously described12 and for the assess-
ment of gene expression of cytokine by qPCR (Fig. 1 and Table 1). In detail, tissue samples for the assessment of 
gene expression of cytokine by qPCR were preliminary obtained, in each mouse, after cecum removal, from the 
mid colon. The remaining colonic segments (proximal and distal colon) were pooled and further processed for 
LPMC isolation.
RNA extraction, reverse transcription and qPCR. Tissue sample were collected from each mouse in 
RNAlater (Ambion - Thermo Fisher Scientific, Europe), stored overnight at 4 °C and then stored at −80 °C until 
RNA extraction. Total RNA extraction was performed by RNeasy Mini Kit Plus (Qiagen) according with manu-
facturer’s instructions. RNA quality was assessed by gel electrophoresis and spectrophotometry measuring OD 
260/280. 1μg of RNA/sample was retrotranscribed into complementary DNA (cDNA) using TaqMan® Reverse 
Transcription Reagents (ThermoFisher Scientific). Cytokine of interest was then amplified by qPCR using Syber 
Green chemistry (Fast SYBR Green Master mix, ThermoFisher Scientific). Each sample was processed with tech-
nical triplicates. Reactions were run in a ViiA™ 7 Real-Time PCR System (Applied Biosystems). All primer sets 
were designed to span an intron and utilized for real-time PCR (Supplementary Table S3). Cytokine RNA expres-
sion was calculated relative to the housekeeping HPRT gene on the basis of the ΔΔCt algorithm51 and expressed 
as Arbitrary Units (AU).
Bacterial DNA extraction. For each group of mice, the pellets were collected in sterile conditions and 
stored at −80 °C until extraction of nucleic acids. The bacterial genomic DNA extraction was carried out with 
FastDNA SpinKit for feces (MP Biomedicals, Santa Ana, CA, USA) following the manufacture’s instructions. 
DNA quality was assessed by gel electrophoresis and spectrophotometry, measuring OD 260/280.
Pyrosequencing and data analysis. The 16S rRNA gene was amplified using the special fusion primer 
set specific for V3−V5 hypervariable regions, and the FastStart High Fidelity PCR system (Roche Life Science, 
Milano, Italy), as previously described52. The 454 pyrosequencing was carried out on the GS FLX + system 
(Roche) using the XL + chemistry following the manufacture’s recommendations. We obtained a total of 
1,453,737 16S rDNA reads, with a mean of 29,074.74 sequences per sample. Average sequence lengths were 
586 nt (±SD 32). Raw 454 files were demultiplexed using Roche’s.sff file software. Reads were pre-processed 
using the MICCA pipeline (version 1.5, http://compmetagen.github.io/micca/)53. Forward and reverse primer 
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trimming and quality filtering were performed using micca-preproc truncating reads shorter than 300 nt (qual-
ity threshold = 18). Denovo sequence clustering, chimera filtering and taxonomy assignment were performed 
by micca-otu-denovo. Operational Taxonomic Units (OTUs) were assigned by clustering the sequences with a 
threshold of 97% pair-wise identity. The representative sequences were classified using the RDP classifier version 
2.7 against RDP 11 database (update 5) of 16S rRNA. Template-guided multiple sequence alignment was per-
formed using PyNAST (version 0.1) against the multiple alignment of the Greengenes 16S rRNA gene database 
(release 13_05) and filtering at 97% similarity.
A total of 943 Operational Taxonomic Units (OTUs) were assigned by clustering the sequences with a thresh-
old of 97% pair-wise identity.
Alpha diversity was estimated by Observed OTUs and Shannon entropy. Rarefaction curves were calculated 
by number of observed OTUs for different values of the rarefaction depth for each sequenced sample by using 
PAST3 tool, in order to evaluate if the sequences were sufficient to cover the biodiversity of microbial communi-
ties (Supplementary Fig. S6). Sampling heterogeneity was reduced by rarefaction, obtaining 10‘141 sequences per 
sample (Supplementary Datafile 1).
Beta diversity was performed to evaluate differences in overall bacterial communities by Principal Coordinates 
Analysis (PCoA) and Non-metric Multidimensional Scaling (NMDS), based on Bray-Curtis dissimilarities, using 
the phyloseq package of the R software suite54. The significance of between-groups differentiation on Bray-Curtis 
dissimilarity was assessed by PERMANOVA using the adonis() function of the R package vegan with 999 
permutations.
To infer the functional contribution of microbial communities (revealing functional classes; KEGG categories) 
on 16S rDNA sequencing data set, we applied Phylogenetic Investigation of Communities by Reconstruction of 
Unobserved States- PICRUSt29, a computational approach useful to infer the functional contribution of microbi-
ome based on 16S rRNA dataset. We obtained the final output from metagenome prediction as an annotated table 
of predicted gene family counts for each sample, where the encoded function of each gene family be orthologous 
groups or other identifiers such as KEGG orthologs (KOs).
Statistical analyses. Statistical differences in mice body weight and in cytokine RNA expression data were 
evaluated using parametric and non-parametric statistic as appropriated through GraphPad Prism software 
(GraphPad Software, San Diego, CA). A p-value <0.05 was considered statistically significant.
Metagenomic biomarker discovery and related statistical significance were assessed by using the linear dis-
criminant analysis (LDA) effect size (LEfSe) method55, based on the bacterial relative abundances. In LEfSe, 
Kruskal–Wallis rank-sum test is used to identify significantly different taxa abundances among groups of mice 
considering different genotype and stabulation condition (cohousing or reared separately), and LDA to esti-
mate the size effect of each feature. An alpha significance level of 0.05, either for the factorial Kruskal-Wallis test 
among classes or for the pairwise Wilcoxon test between subclasses, was used. A size-effect threshold of 2.0 on 
the logarithmic LDA score was applied for discriminative microbial biomarkers. LEfSe was also performed on 
PICRUSt data to discover bacterial functional biomarkers among groups of mice based on different genotype and 
stabulation conditions.
Spearman’s r correlation analysis was performed to correlate bacterial relative abundances (with relative abun-
dance > 0.1%) and cytokines expression (RT-qPCR on IL-6, IL-17, IFN-γ, IL-10 and TGF-β normalized using the 
HK gene CD3) under different conditions (stabulation, genetic background, colitis). Spearman’s correlation tests 
were computed using the psych R package56 and p-values were corrected for multiple comparison controlling the 
false discovery rate57.
Data Availability
Raw 454 files are available at the European Nucleotide Archive under the accession study PRJEB22726.
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